• DOI:10.1038/nrc1120
Corpus ID: 41441023

Curing metastatic cancer: lessons from testicular germ-cell tumours

@article{Masters2003CuringMC,
  title={Curing metastatic cancer: lessons from testicular germ-cell tumours},
  author={J. Masters and B. K{\"o}berle},
  journal={Nature Reviews Cancer},
  year={2003},
  volume={3},
  pages={517-525}
}

J. Masters, B. Köberle

Published 2003

Biology, Medicine

Nature Reviews Cancer

View on Nature

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed

Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.